Denticleless E3 Ubiquitin Protein Ligase Homolog as a Potential Biomarker for Adrenocortical Carcinoma Screening

<i>(DTL)</i> exhibits potential as a novel biomarker for distinguishing between benign and malignant adrenocortical tumors and may serve as a prognostic indicator for ACC.

Authors

Institutions

Publication Details

Journal
Endocrine Metabolic & Immune Disorders - Drug Targets
Published
2025-06-20
DOI
https://doi.org/10.2174/0118715303334496250518033852
Primary Topic
Adrenal and Paraganglionic Tumors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Denticleless E3 Ubiquitin Protein Ligase Homolog as a Potential Biomarker for Adrenocortical Carcinoma Screening

Xinghuan Liang, Sheng Chen, Lixing Pang, Xiaoxia Lü et al.
Endocrine Metabolic & Immune Disorders - Drug Targets
Adrenal and Paraganglionic Tumors
article

Denticleless E3 Ubiquitin Protein Ligase Homolog as a Potential Biomarker for Adrenocortical Carcinoma Screening

Xinghuan Liang, Sheng Chen, Lixing Pang, Xiaoxia Lü, Li Li, Zuojie Luo, Xin Yan, Decheng Lü
article en

Abstract

<i>(DTL)</i> exhibits potential as a novel biomarker for distinguishing between benign and malignant adrenocortical tumors and may serve as a prognostic indicator for ACC.

Endocrine Metabolic & Immune Disorders - Drug TargetsVol. 25
Guangxi Medical University (CN), First Affiliated Hospital of GuangXi Medical University (CN), The Second Nanning People's Hospital (CN)
Openalex Percentile: Top 74%
Adrenal and Paraganglionic Tumors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.